miniVIDAS
Device
bioMerieux
Total Payments
$16,865
Transactions
7
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $1,500 | 1 | 0 |
| 2017 | $15,365 | 6 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $16,865 | 7 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PCT Antibiotic Consensus Trial | bioMerieux | $7,617 | 0 |
| PCT and antibiotic stewardship | bioMerieux | $3,167 | 0 |
| PCT in children with pneumonia | bioMerieux | $2,759 | 0 |
| PCT Antibiotic Consensus Study | bioMerieux | $1,822 | 0 |
| Procalcitonin Antibiotic Consensus Trial (ProACT) | bioMerieux | $1,500 | 0 |
Top Doctors Receiving Payments for miniVIDAS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Salt Lake City, UT | $16,865 | 7 |
Ad
Manufacturing Companies
- bioMerieux $16,865
Product Information
- Type Device
- Total Payments $16,865
- Total Doctors 0
- Transactions 7
About miniVIDAS
miniVIDAS is a device associated with $16,865 in payments to 0 healthcare providers, recorded across 7 transactions in the CMS Open Payments database. The primary manufacturer is bioMerieux.
Payment data is available from 2017 to 2018. In 2018, $1,500 was paid across 1 transactions to 0 doctors.
The most common payment nature for miniVIDAS is "Unspecified" ($16,865, 100.0% of total).
miniVIDAS is associated with 5 research studies, including "PCT Antibiotic Consensus Trial" ($7,617).